About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
May 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: Pharma Industry Image
Purdue Pharma Settlement
The FDA announced this afternoon a settlement whereby Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin – … Continue reading
Posted in Current Affairs, Pharma Industry Image
Comments Off on Purdue Pharma Settlement
State Status on HPV Mandates
Recently I have submitted posts regarding the executive order issued by Texas governor Rick Perry that mandated HPV vaccine Gardasil for teenage girls and on the Merck decision to pull back its lobbying program related to the same. The New … Continue reading
Posted in Current Affairs, Pharma Industry Image, Proposed Legislation
Comments Off on State Status on HPV Mandates
U-Turn on Gardasil Program – Balancing Product Promotion with Corporate Reputation
As we have all heard by now, Merck has decided to cease its lobbying efforts to promote its position that its HPV vaccine Gardasil should be mandatory for children. The HPV vaccine program has been fraught with controversy. First, while … Continue reading
Posted in Pharma Industry Image
Comments Off on U-Turn on Gardasil Program – Balancing Product Promotion with Corporate Reputation
AIDS Perspectives and Values
TORONTO, ONTARIO – Today is my last day at the XVI International AIDS Conference. In case you’ve been worried that you’ve been missing anything about FDA, I’ve kept tabs while I’ve been gone and so far, no speeches, no testimony … Continue reading
Posted in Current Affairs, Pharma Industry Image
Comments Off on AIDS Perspectives and Values
Prevention Pill Research – An HIV Opportunity for Pharma
From Toronto. Last night, the XVI International AIDS Conference opened in Toronto, Ontario. It is now a biennial conference and it is my sixth, having attended Florence, Amsterdam, Berlin, Vancouver and Geneva previously. For what it is worth, like the … Continue reading
Posted in Clinical Trials, Current Affairs, Pharma Industry Image
1 Comment